PeptideStack
5.2kquestions
20kanswers
220users

Does magnesium tell me anything about hepatic fat on liraglutide?

Asked 1 Feb 2025Modified 16 months agoViewed 20k times
12

Stated plainly: magnesium · liraglutide.

This is one of those things that everyone repeats and nobody derives.

This matters practically, not just academically, because it changes what I would do next.

Why does this happen, and what would falsify the usual explanation?

liver-enzymes
liver-enzymes

ALT, AST, GGT and ALP: what they do and do not indicate about hepatic fat, why enzymes are a poor surrogate for histology, and where non-invasive…

91 questions
mash
mash

Metabolic dysfunction-associated steatohepatitis: histological endpoints, resolution without worsening fibrosis, fibrosis improvement by stage,…

56 questions
bloodwork
bloodwork

Laboratory monitoring: which panels are worth ordering, sensible intervals, reference-range versus optimal-range arguments, and how to read a…

296 questions
electrolytes
electrolytes

Sodium, potassium and magnesium during reduced intake and GI losses: what the symptoms of a shortfall look like, when a panel is worth drawing,…

72 questions
liraglutide
liraglutide

A once-daily GLP-1 receptor agonist and the compound that established the class. Still relevant for its shorter half-life, its paediatric and…

235 questions
shareeditfollowflag
DC
askedDr_Idris_Coulibaly33k1371 Feb 2025
Worth adding the time of day, since a couple of these have a diurnal swing. – tess_amankwah 6 months ago
Voting to keep this open — it is more specific than it first looks. – ben_akintola 5 months ago
add a comment

3 Answers

Sorted by votes
16

Start with the pattern. A hepatocellular pattern with alanine aminotransferase above aspartate aminotransferase points one way; a cholestatic pattern with alkaline phosphatase and gamma-glutamyl transferase points another.

Reference upper limits around forty units per litre for ALT are conventional rather than physiological; several groups have argued for limits closer to thirty for men and twenty-five for women.

Gamma-glutamyl transferase is sensitive and unspecific: it rises with alcohol, with several medications and with fatty liver, and an isolated elevation rarely changes anything on its own.

Laboratory-specific reference intervals for transaminases vary enough that cross-laboratory comparison of borderline values is unreliable.

New training, alcohol and over-the-counter products first. Then the interesting hypotheses.

shareimprove this answerflag
DW
answereddana_wexler11k1628 Feb 2025
5Does this hold for a non-fasting draw, or does the triglyceride figure make that a different conversation? – sian_llewellyn 6 months ago
4Confirming that a repeat two weeks later resolved what looked alarming on a single draw. – m_haraldsen 4 months ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
10

Answering this needs the magnitude in multiples of the upper reference limit, because the thresholds that matter clinically are defined that way and not in absolute units.

Hy's law describes the combination that matters: transaminases above three times the upper limit together with bilirubin above twice the upper limit and no cholestatic explanation. That combination is a signal; isolated mild transaminase elevation is not.

More usefully, an isolated result three weeks after starting anything is difficult to interpret. A baseline taken before starting makes the same result trivially interpretable, which is the argument for baselines.

Hy's law and its variants are the standard framework for identifying drug-induced liver injury in trials and are why bilirubin is measured alongside transaminases rather than instead.

Nothing here is medical advice. An abnormal result needs somebody who can take a history and examine you.

Get a baseline before you start anything, because it converts an uninterpretable result into an interpretable one for the cost of one blood draw.

edited 7 Apr 2025 by Dr_Bram_Verhoeven — reworded for clarity after a comment

shareimprove this answerflag
DV
answeredDr_Bram_Verhoeven84k24811 Mar 2025
6

Reference intervals for alanine aminotransferase differ between laboratories and have been revised downward over time, so the same value can be normal on one report and elevated on another.

Creatine kinase, alkaline phosphatase and bilirubin together tell you which compartment the abnormality is in, and ordering the transaminases alone throws that information away.

Put another way, very rapid weight loss can transiently worsen liver biochemistry, which is one of several arguments against pursuing the steepest possible trajectory.

Research-use material of unknown content is an unquantifiable variable in any such attribution.

Transaminases plus bilirubin plus alkaline phosphatase, or you have not measured enough to conclude anything.

shareimprove this answerflag
FR
answeredfib4_reader24k276 Feb 2025
2Minor: haemolysis inflates potassium enough to cause a fright over what is a handling artefact. – ten_mg_vial 6 months ago
Small correction: eGFR is an estimate derived from creatinine, not a measurement, and the equation used matters. – Dr_Nadia_Farsi 4 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.